TY - JOUR
T1 - Tuberculosis comorbidity with communicable and non-communicable diseases
T2 - integrating health services and control efforts
AU - Marais, Ben J
AU - Lönnroth, Knut
AU - Lawn, Stephen D
AU - Migliori, Giovanni Battista
AU - Mwaba, Peter
AU - Glaziou, Philippe
AU - Bates, Matthew
AU - Colagiuri, Ruth
AU - Zijenah, Lynn
AU - Swaminathan, Soumya
AU - Memish, Ziad A
AU - Pletschette, Michel
AU - Hoelscher, Michael
AU - Abubakar, Ibrahim
AU - Hasan, Rumina
AU - Zafar, Afia
AU - Pantaleo, Guiseppe
AU - Craig, Gill
AU - Kim, Peter
AU - Maeurer, Markus
AU - Schito, Marco
AU - Zumla, Alimuddin
N1 - Copyright © 2013 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.
PY - 2013/5/1
Y1 - 2013/5/1
N2 - Recent data for the global burden of disease reflect major demographic and lifestyle changes, leading to a rise in non-communicable diseases. Most countries with high levels of tuberculosis face a large comorbidity burden from both non-communicable and communicable diseases. Traditional disease-specific approaches typically fail to recognise common features and potential synergies in integration of care, management, and control of non-communicable and communicable diseases. In resource-limited countries, the need to tackle a broader range of overlapping comorbid diseases is growing. Tuberculosis and HIV/AIDS persist as global emergencies. The lethal interaction between tuberculosis and HIV coinfection in adults, children, and pregnant women in sub-Saharan Africa exemplifies the need for well integrated approaches to disease management and control. Furthermore, links between diabetes mellitus, smoking, alcoholism, chronic lung diseases, cancer, immunosuppressive treatment, malnutrition, and tuberculosis are well recognised. Here, we focus on interactions, synergies, and challenges of integration of tuberculosis care with management strategies for non-communicable and communicable diseases without eroding the functionality of existing national programmes for tuberculosis. The need for sustained and increased funding for these initiatives is greater than ever and requires increased political and funder commitment.
AB - Recent data for the global burden of disease reflect major demographic and lifestyle changes, leading to a rise in non-communicable diseases. Most countries with high levels of tuberculosis face a large comorbidity burden from both non-communicable and communicable diseases. Traditional disease-specific approaches typically fail to recognise common features and potential synergies in integration of care, management, and control of non-communicable and communicable diseases. In resource-limited countries, the need to tackle a broader range of overlapping comorbid diseases is growing. Tuberculosis and HIV/AIDS persist as global emergencies. The lethal interaction between tuberculosis and HIV coinfection in adults, children, and pregnant women in sub-Saharan Africa exemplifies the need for well integrated approaches to disease management and control. Furthermore, links between diabetes mellitus, smoking, alcoholism, chronic lung diseases, cancer, immunosuppressive treatment, malnutrition, and tuberculosis are well recognised. Here, we focus on interactions, synergies, and challenges of integration of tuberculosis care with management strategies for non-communicable and communicable diseases without eroding the functionality of existing national programmes for tuberculosis. The need for sustained and increased funding for these initiatives is greater than ever and requires increased political and funder commitment.
KW - Acquired Immunodeficiency Syndrome
KW - Coinfection
KW - Communicable Disease Control
KW - Communicable Diseases
KW - Comorbidity
KW - Diabetes Mellitus
KW - Global Health
KW - Health Services Needs and Demand
KW - Humans
KW - Mycobacterium tuberculosis
KW - National Health Programs
KW - Risk Factors
KW - Socioeconomic Factors
KW - Tuberculosis
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
KW - Review
U2 - 10.1016/S1473-3099(13)70015-X
DO - 10.1016/S1473-3099(13)70015-X
M3 - Special issue
C2 - 23531392
SN - 1473-3099
VL - 13
SP - 436
EP - 448
JO - The Lancet. Infectious diseases
JF - The Lancet. Infectious diseases
IS - 5
ER -